TY - JOUR
T1 - The Rise and Risk of Delta-8 THC (Delta-8-Tetrahydrocannabinol)
AU - Nachnani, Rahul
AU - Raup-Konsavage, Wesley M.
AU - Vrana, Kent E.
N1 - Funding Information:
This work was supported by a sponsored research agreement from PA Options for Wellness (a Pennsylvania-approved medical marijuana clinical registrant) and the Penn State Elliot S. Vesell endowment (both to KEV). The Penn State College of Medicine is a Pennsylvania-approved Academic Clinical Research Center.
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature Switzerland AG.
PY - 2022/12
Y1 - 2022/12
N2 - Purpose of Review: The purpose of this review is to differentiate delta-8-tetrahydrocannabinol (delta-8) and delta-9-tetrahydrocannabinol (delta-9) as they relate to human health and disease. Recent Findings: Delta-8 is a novel cannabinoid becoming increasingly used following the passage of the US Agricultural Improvement Act of 2018 and the deregulation of hemp. Cannabis spp. naturally produces little delta-8. Retail delta-8 products consist of synthetic delta-8 chemically converted from cannabidiol (CBD). Delta-8 marketing claims a “softer, gentler high” compared to delta-9, but limited data exist to support this claim. A recent screen of delta-8 products found that the majority contained heavy metal contamination and that the reported vs. actual compositions of commercial products did not agree. Summary: The effects of delta-8 on the human body remain largely unexplored, as do the pharmacokinetic differences between delta-8 and delta-9. Because the dietary supplement market is largely unregulated, these products are not tested for contaminants that may also have harmful effects.
AB - Purpose of Review: The purpose of this review is to differentiate delta-8-tetrahydrocannabinol (delta-8) and delta-9-tetrahydrocannabinol (delta-9) as they relate to human health and disease. Recent Findings: Delta-8 is a novel cannabinoid becoming increasingly used following the passage of the US Agricultural Improvement Act of 2018 and the deregulation of hemp. Cannabis spp. naturally produces little delta-8. Retail delta-8 products consist of synthetic delta-8 chemically converted from cannabidiol (CBD). Delta-8 marketing claims a “softer, gentler high” compared to delta-9, but limited data exist to support this claim. A recent screen of delta-8 products found that the majority contained heavy metal contamination and that the reported vs. actual compositions of commercial products did not agree. Summary: The effects of delta-8 on the human body remain largely unexplored, as do the pharmacokinetic differences between delta-8 and delta-9. Because the dietary supplement market is largely unregulated, these products are not tested for contaminants that may also have harmful effects.
UR - http://www.scopus.com/inward/record.url?scp=85142367761&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142367761&partnerID=8YFLogxK
U2 - 10.1007/s40429-022-00456-1
DO - 10.1007/s40429-022-00456-1
M3 - Review article
AN - SCOPUS:85142367761
SN - 2196-2952
VL - 9
SP - 622
EP - 629
JO - Current Addiction Reports
JF - Current Addiction Reports
IS - 4
ER -